54
Participants
Start Date
December 21, 2020
Primary Completion Date
February 7, 2022
Study Completion Date
February 7, 2022
Melflufen
Powder for solution for i.v. infusion
Dexamethasone
Oral tablets
Daratumumab
Solution for s.c. injection
University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno
"University Multiprofile Hospital for Active Treatment Sveti Georgi, Plovdiv, Clinical Hematology Clinic", Plovdiv
Specialized Hospital for Active Treatment of Hematological Diseases, Clinical Hematology Clinic, Sofia
University Hospital Hradec Kralove, 4th Internal Clinic of Hematology, Kralovice
University Hospital Ostrava, Clinic of Hematooncology, Ostrava-Poruba
General University Hospital in Prague, 1st Internal Clinic - Clinic of Hematology, Prague
JSC K. Eristavi National Center of Experimental and Clinical Surgery, Tbilisi
Malkhaz Katsiashvili Multiprofile EMC LTD, Tbilisi
St. Marien-Hospital Siegen gem. GmbH, Clinic for Hematology, Medical Oncology and Palliative Medicine, Siegen
Alexandra General Hospital, Therapeutic Clinic, Athens
"General Hospital of Athens Evangelismos, Department of Hematology and Lymphoma", Athens
Oslo University Hospital, Ulleval University Hospital, Oslo Myeloma Center, Oslo
Independent Public Healthcare Facility Municipal Hospitals, Teaching Department of Hematology And Prevention of Neoplastic Diseases, Chorzów
University Clinical Center, Teaching Department of Hematology and Transplantology, Gdansk
Independent Public Healthcare Facility University Hospital in Krakow, Teaching Unit of the Hematology Department, Krakow
Nicolaus Copernicus Provincial Multispecialty Oncology and Traumatology Center in Lodz, Lodz
St. John of Dukla Oncology Center of Lublin Region, Department of Hematology and Bone Marrow Transplantation, Lublin
Leningrad Regional Clinical Hospital, Saint Petersburg
V.D. Seredavin Samara Regional Clinical Hospital, Samara
Clinical Center of Serbia, Belgrade
Hospital Clinic of Barcelona, Department of Hematology, Barcelona
Cherkasy Regional Oncology Dispensary, Regional Treatment and Diagnostic Hematology Center, Cherkasy
Chernihiv Medical Center of Modern Oncology, Hematology Department, Chernihiv
City Clinical Hospital No. 4 City Hematology Center, Dnipro
Kyiv City Clinical Hospital No. 9, Hematology Department No. 1, Kyiv
National Institute of Cancer, Research Department of Hemoblastosis Chemotherapy and Adjuvant Treatment Methods, Department of Oncohematology with Adjuvant Treatment Methods Group, Kyiv
Lead Sponsor
Oncopeptides AB
INDUSTRY